EMD-25471

Single-particle
3.59 Å
EMD-25471 Deposition: 19/11/2021
Map released: 06/04/2022
Last modified: 28/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-25471

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-7swd summary report (pdf.gz) Map-7swd FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

Structure of EBOV GP lacking the mucin-like domain with 1C11 scFv and 1C3 Fab bound

EMD-25471

Single-particle
3.59 Å
EMD-25471 Deposition: 19/11/2021
Map released: 06/04/2022
Last modified: 28/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Ebola virus - Gabon (1994-1997), Zaire ebolavirus
Sample: Complex of EBOV GP lacking the mucin-like-domain with 1C11 scFv and 1C3 Fab
Fitted models: 7swd

Deposition Authors: Milligan JC, Yu X
Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses.
PUBMED: 35303429
DOI: doi:10.1016/j.cell.2022.02.023
ISSN: 1097-4172